Two Sigma Investments’s Landos Biopharma, Inc. Common Stock LABP Stock Holding History

Two Sigma Investments’s Portfolio LABP Stock Details LABP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,942	Closed	-$13K	–	3181
2022 Q3	$13K	Sell	1,942 -2,704	-58%	-$23.5K	﹤0.01%	2404
2022 Q2	$34K	Sell	4,646 -2,719	-37%	-$24.7K	﹤0.01%	2373
2022 Q1	$109K	Buy	7,365 +1,887	+34%	+$48K	﹤0.01%	2424
2021 Q4	$263K	Buy	+5,478	New	+$576K	﹤0.01%	3736
2021 Q2	–	Sell	-2,415	Closed	-$233K	–	4724
2021 Q1	$233K	Buy	+2,415	New	+$315K	﹤0.01%	3530

Other funds holding LABP

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

SGCA

Steel Grove Capital Advisors Memphis, Tennessee $949M AUM 23.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments's LABP Position: Q4 2022 in Review

Two Sigma Investments sold out of Landos Biopharma, Inc. Common Stock (LABP) in Q4 2022, closing a stake of 1,942 shares — an estimated $13K sold.

Two Sigma Investments first reported a position in LABP in Q1 2021 and held it in 5 quarters. The position peaked at $263K in Q4 2021. 23 funds tracked by Wall St. Rank hold LABP as of Q4 2022.

Two Sigma Investments reported no remaining Landos Biopharma, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Two Sigma Investments sold 1,942 Landos Biopharma, Inc. Common Stock shares in Q4 2022, an estimated $13K.
Two Sigma Investments first reported a position in Landos Biopharma, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
Two Sigma Investments's Landos Biopharma, Inc. Common Stock position peaked at $263K in Q4 2021.
23 funds tracked by Wall St. Rank held Landos Biopharma, Inc. Common Stock as of Q4 2022.

Based on Two Sigma Investments's 13F filing for Q4 2022, filed 14 Feb 2023.